Purpose: Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis are at risk for multiple nerve sheath tumors and premature mortality. Traditional magnetic resonance imaging (MRI) has limited ability to assess disease burden accurately. The aim of this study was to establish an international cohort of patients with quantified whole-body internal tumor burden and to correlate tumor burden with clinical features of disease. Methods: We determined the number, volume, and distribution of internal nerve sheath tumors in patients using whole-body MRI (WBMRI) and three-dimensional computerized volumetry. We quantified the distribution of tumor volume across body regions and used unsupervised cluster analysis to group patients based on tu...
Objective: To investigate the risk and pattern of tumors in italian neurofibromatosis type 1 (NF1) p...
International audienceBackground: Malignant peripheral nerve sheath tumors (MPNSTs) are a serious co...
Introduction: Gliomas in the brain and the optic pathway affect up to 20% of all children with neuro...
Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis are at risk for multiple nerve she...
Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis share a predisposition to develop ...
Purpose To determine the metabolically active whole-body tumor volume (WB-MTV) on F-18-fluoro-deoxyg...
Whole-Body MRI (WBMRI) has been available for clinical use since the early 2000’s, providing a non-i...
People with neurofibromatosis 1 (NF1) have multiple benign neurofibromas and a 10 % lifetime risk of...
International audienceUNLABELLED: ABSTRACT: OBJECTIVE: To identify clinical characteristics associat...
BACKGROUND: The neurofibromatoses (NF) are genetic disorders. Increased risks of some cancers in peo...
Background:The neurofibromatoses (NF) are genetic disorders. Increased risks of some cancers in peop...
ObjectivesThe Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Col...
International audienceABSTRACT: Objectives: To assess associations between subcutaneous neurofibroma...
Background: Cross sectional studies have shown that 1-2% of patients with neurofibromatosis 1 (NF1) ...
Neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SWN) are rare co...
Objective: To investigate the risk and pattern of tumors in italian neurofibromatosis type 1 (NF1) p...
International audienceBackground: Malignant peripheral nerve sheath tumors (MPNSTs) are a serious co...
Introduction: Gliomas in the brain and the optic pathway affect up to 20% of all children with neuro...
Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis are at risk for multiple nerve she...
Patients with neurofibromatosis 1 (NF1), NF2, and schwannomatosis share a predisposition to develop ...
Purpose To determine the metabolically active whole-body tumor volume (WB-MTV) on F-18-fluoro-deoxyg...
Whole-Body MRI (WBMRI) has been available for clinical use since the early 2000’s, providing a non-i...
People with neurofibromatosis 1 (NF1) have multiple benign neurofibromas and a 10 % lifetime risk of...
International audienceUNLABELLED: ABSTRACT: OBJECTIVE: To identify clinical characteristics associat...
BACKGROUND: The neurofibromatoses (NF) are genetic disorders. Increased risks of some cancers in peo...
Background:The neurofibromatoses (NF) are genetic disorders. Increased risks of some cancers in peop...
ObjectivesThe Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Col...
International audienceABSTRACT: Objectives: To assess associations between subcutaneous neurofibroma...
Background: Cross sectional studies have shown that 1-2% of patients with neurofibromatosis 1 (NF1) ...
Neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis (SWN) are rare co...
Objective: To investigate the risk and pattern of tumors in italian neurofibromatosis type 1 (NF1) p...
International audienceBackground: Malignant peripheral nerve sheath tumors (MPNSTs) are a serious co...
Introduction: Gliomas in the brain and the optic pathway affect up to 20% of all children with neuro...